Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Ping Lü

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4340-2670; OpenAlex author ID A5101438512. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. Erianin Suppresses Pancreatic Cancer Progression by Inducing Cell Cycle Arrest and Ferroptosis. Last author DOI 10.2147/cmar.s540437↗
  2. Deciphering fatty acid biosynthesis-driven molecular subtypes in pancreatic ductal adenocarcinoma with prognostic insights. Last author DOI 10.1007/s13402-024-00953-7↗
  3. Integrated single-cell multiomics analysis reveals novel candidate markers for prognosis in human pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41421-021-00366-y↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Qu · 1 shared paper, 2025 · strength 0.33
  2. Junyi Xu · 1 shared paper, 2024 · strength 0.31
  3. Jing Xue · 1 shared paper, 2024 · strength 0.31
  4. Danqi Fu · 1 shared paper, 2022 · strength 0.15
  5. Yang Liu · 1 shared paper, 2022 · strength 0.15
  6. Xiaoying Fan · 1 shared paper, 2022 · strength 0.15
  7. Fuchou Tang · 1 shared paper, 2022 · strength 0.15
  8. Xinglong Wu · 1 shared paper, 2022 · strength 0.15
  9. Jihui Hao · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.